Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06674811 · ClinicalTrials.gov registry record

Biomarkers of Resiliency In Childhood Cancer Surgery

A clinical trial of Sarcoma and Neuroblastoma, sponsored by Mayo Clinic.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT06674811: Recruiting study of Sarcoma and Neuroblastoma, sponsored by Mayo Clinic.

NCT06674811 is a study of Sarcoma and Neuroblastoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06674811, a study of Sarcoma and Neuroblastoma, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

This observational study is to better understand how children and their families recover after the stress of major surgery for cancer so that investigators can create ways to improve resilience during recovery. The main questions it aims to answer are: 1. Can information obtained from patients and their caregivers wearing smartwatches and answering questionnaires be used to measure how patients are recovering from surgery? 2. Are there specific patterns in patients' circulating proteins and metabolites that are associated with stress after surgery? Participants, including pediatric patients undergoing surgery for cancer and their primary caregiver, will be asked to: * wear a smartwatch * complete questionnaires * allow for extra blood to be drawn for this research study when they are having their regular blood draws for clinical purposes These actions will occur at baseline prior to patients' surgery and then afterwards for up to one year. There are no changes to participants' clinical care or surgical care as a result of the study. Investigators will also collect participants' clinical information and cancer-specific outcomes. Participants will be remunerated for their time.

Primary Outcome

Using smartwatches, we will assess motor activity by minutes spent being sedentary, active, or highly active, heart rate, and sleep duration and stages. This information will be collected before and after surgical resection. Data from the smartwatches syncs with Garmin connect using Fitabase which allows the study team to monitor and analyze the data. Results will be correlated with questionnaires responses, to see if there are digital biomarker patterns associated with return to baseline qualit

Conditions Studied

Sarcoma Neuroblastoma Pediatric Cancer Childhood Soft Tissue Sarcoma Wilms Tumor and Other Childhood Kidney Tumors Childhood Malignant Liver Neoplasm Childhood Bone Sarcoma Childhood Malignant Intestinal Neoplasm Childhood Malignant Lung Neoplasm Childhood Malignant Ovarian Neoplasm

Interventions

  • OTHER Blood Draw
  • OTHER Wearing Smartwatch
  • OTHER Patient Report Outcomes
  • OTHER Clinical Data Review

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-01-16
Est. Completion 2030-01
Mayo Clinic

2,844 total trials

What NCT06674811 shows while recruiting

NCT06674811 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (96% lower).

The record links to 10 conditions, with Sarcoma appearing as the primary indexed condition, and to 4 interventions - of which Blood Draw is the first listed.

NCT06674811 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06674811 about?

NCT06674811 is a clinical study titled "Biomarkers of Resiliency In Childhood Cancer Surgery". This observational study is to better understand how children and their families recover after the stress of major surgery for cancer so that investigators can create ways to improve resilience during recovery. The main questions it aims to answer are: 1. Can information obtained from patients and ...

What is the current status of trial NCT06674811?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-01-16. Estimated completion is 2030-01.

What conditions does trial NCT06674811 study?

This clinical trial studies the following conditions: Sarcoma, Neuroblastoma, Pediatric Cancer, Childhood Soft Tissue Sarcoma, Wilms Tumor and Other Childhood Kidney Tumors.

What interventions are being tested in trial NCT06674811?

The interventions under investigation include: Blood Draw (OTHER), Wearing Smartwatch (OTHER), Patient Report Outcomes (OTHER), Clinical Data Review (OTHER).

Who is sponsoring clinical trial NCT06674811?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06674811 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sarcoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06674811's enrollment target sits among peer trials

40 75th of 122 higher than 46 of 122 other Sarcoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

More recruiting context for NCT06674811

Source: ClinicalTrials.gov NCT06674811, the US trial registry maintained by the National Library of Medicine. NCT06674811 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.